Business Description
TrivarX Ltd
NAICS : 541711
ISIN : AU0000300196
Description
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 53 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -16.4 | |||||
| Beneish M-Score | -4.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 45 | |||||
| 3-Year EPS without NRI Growth Rate | 49 | |||||
| 3-Year FCF Growth Rate | 46.3 | |||||
| 3-Year Book Growth Rate | -50.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.02 | |||||
| 9-Day RSI | 57.81 | |||||
| 14-Day RSI | 54.09 | |||||
| 6-1 Month Momentum % | -40 | |||||
| 12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.78 | |||||
| Quick Ratio | 0.78 | |||||
| Cash Ratio | 0.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -60.8 | |||||
| Shareholder Yield % | -59.99 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -12409.09 | |||||
| Net Margin % | -14181.82 | |||||
| ROE % | -17.47 | |||||
| ROA % | -15.1 | |||||
| ROIC % | -25.06 | |||||
| ROC (Joel Greenblatt) % | -2350.55 | |||||
| ROCE % | -17.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.71 | |||||
| EV-to-EBIT | -4.96 | |||||
| EV-to-EBITDA | -5.31 | |||||
| EV-to-FCF | -1.78 | |||||
| Earnings Yield (Greenblatt) % | -20.16 | |||||
| FCF Yield % | -50.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TrivarX Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.005 | ||
| Beta | 0.96 | ||
| Volatility % | 56.23 | ||
| 14-Day RSI | 54.09 | ||
| 14-Day ATR (A$) | 0.001247 | ||
| 20-Day SMA (A$) | 0.0157 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range (A$) | 0.014 - 0.045 | ||
| Shares Outstanding (Mil) | 464.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TrivarX Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TrivarX Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
TrivarX Ltd Frequently Asked Questions
What is TrivarX Ltd(ASX:TRI)'s stock price today?
The current price of ASX:TRI is A$0.02. The 52 week high of ASX:TRI is A$0.05 and 52 week low is A$0.01.
When is next earnings date of TrivarX Ltd(ASX:TRI)?
The next earnings date of TrivarX Ltd(ASX:TRI) is 2025-02-28 Est..
Does TrivarX Ltd(ASX:TRI) pay dividends? If so, how much?
TrivarX Ltd(ASX:TRI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers